Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase II trial of intraoperative intraperitoneal cisplatin chemoperfusion during cytoreductive surgery for stage III ovarian cancer
2015-000418-23Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in ovarian cancer (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Tissue penetration distance of cisplatin in peritoneal tumor tissue nodules. Started Jun 2015; status: completed.
02
Drugs
cisplatin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2015-000418-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000418-23.